Real-world comparison of major bleeding risk among non-valvular atrial fibrillation patients initiated on apixaban, dabigatran, rivaroxaban, or warfarin. A propensity score matched analysis. Thromb Haemost - Lip, GY; Keshishian, A; Kamble, S (2016)
Epub ahead of print.